NCT04645589 - Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

June 13, 2025

Study Completion Date

June 13, 2025

Conditions

Lupus Nephritis

Interventions

DRUG

Myfortic

There is no treatment allocation. Patients administered Myfortic by prescription that have started before inclusion of the patient into the study will be enrolled.

Trial Locations (6)

105

Novartis Investigative Site, Taipei

10002

Novartis Investigative Site, Taipei

20401

Novartis Investigative Site, Keelung

33305

Novartis Investigative Site, Taoyuan District

83301

Novartis Investigative Site, Kaohsiung City

407219

Novartis Investigative Site, Taichung